98%
921
2 minutes
20
.N, having a half-life of 11 ms, is a highly effective positron emitter that can potentially provide near real-time feedback in proton therapy. There is currently no framework for comparing and validating positron emission imaging ofN. This work describes the development and validation of a Monte Carlo (MC) framework to calculate the images ofN, as well as long-lived isotopes, originating from activation by protons.. The available dual-panel Biograph mCT PET scanner was modeled in GATE and validated by comparing the simulated sensitivity map with the measured one. The distributions ofN and long-lived isotopes were calculated by RayStation and used as the input of GATE simulations. The RayStation/GATE combination was verified using proton beam irradiations of homogeneous phantoms. A 120 MeV pulsed pencil beam with 10protons per pulse was used. Two-dimensional images were created from the GATE output and compared with the images based on the measurements and the 1D longitudinal projection of the full 2D image was used to calculate theN activity range.. The simulated sensitivity in the center of the FoV (5.44%) agrees well with the measured one (5.41%). The simulated and measured 2D sensitivity maps agree in good detail. The relative difference between the measured and simulated positron activity range for bothN and long-lived isotopes is less than 1%. The broadening of theN images relative to those of the longer-lived isotopes can be understood in terms of the large positron range ofN.. We developed and validated a MC framework based on RayStation/GATE to support the in-beam PET method for quality assurance of proton therapy. The inclusion of the very short-lived isotopeN makes the framework useful for developing near real-time verification. This represents a significant step towards translatingN real-time in vivo verification to the clinic.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1088/1361-6560/ad7d5c | DOI Listing |
J Neurooncol
September 2025
Department of Radiation Oncology, Massachusetts General Hospital, Boston, USA.
Purpose: Cranial irradiation is associated with health-related quality of life (HRQoL) deficits in childhood cancer survivors. We investigated the relationship between radiation dose to brain substructures and HRQoL in children with brain tumors treated with proton beam therapy (PBT).
Methods: Data were obtained from children in the Pediatric Proton/Photon Consortium Registry who received PBT for primary brain tumors between 2015 and 2021.
Naunyn Schmiedebergs Arch Pharmacol
September 2025
Department of Hematology, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, 518107, China.
Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy but are increasingly linked to immune-related kidney injury (irKI). This study presents the first bibliometric analysis of irKI research (2000-2025), aiming to identify key trends, mechanistic insights, and pharmacological risk factors. We analyzed 2,179 publications to understand the evolution of irKI research, focusing on areas like T cell-mediated tubular injury, immune system-driven inflammation, and changes in metabolism.
View Article and Find Full Text PDFRadiother Oncol
September 2025
College of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Radiation Oncology, Proton and Radiation Therapy Center, Chang Gung Memorial Hospital-Linkou Medical Center, Taiwan. Electronic address:
Background And Purpose: Emerging evidence suggests that excessive radiation dose to immune cells may impair host immunity and negatively affect cancer prognosis. However, the prognostic impact of the estimated radiation dose to immune cells across different cancer types and treatment modalities remains inconclusive. This meta-analysis aimed to systematically evaluate the association between estimated radiation dose to immune cells and survival outcomes in patients with lung and esophageal cancers undergoing radiotherapy.
View Article and Find Full Text PDFJCO Clin Cancer Inform
August 2025
Telperian, Austin, TX.
Purpose: Lymphocytes play critical roles in cancer immunity and tumor surveillance. Radiation-induced lymphopenia (RIL) is a common side effect observed in patients with cancer undergoing chemoradiation therapy (CRT), leading to impaired immunity and worse clinical outcomes. Although proton beam therapy (PBT) has been suggested to reduce RIL risk compared with intensity-modulated radiation therapy (IMRT), this study used Bayesian counterfactual machine learning to identify distinct patient profiles and inform personalized radiation modality choice.
View Article and Find Full Text PDFRev Sci Instrum
September 2025
HUN-REN Centre for Energy Research, Budapest, Hungary.
A novel medium-current (up to 20 mA), low normalized beam emittance (<1 π mm mrad) electron cyclotron resonance microwave H+ ion source has been developed at the Center for Energy Research in Budapest, Hungary. This high-stability design targets an energy ripple below 1% while delivering a continuous or pulsed proton beam with adjustable pulse duration (0.1-10 ms) and frequency (0.
View Article and Find Full Text PDF